Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.4195
-0.0005 (-0.12%)
Jul 11, 2025, 3:45 PM CET
-3.78%
Market Cap 27.00M
Revenue (ttm) n/a
Net Income (ttm) -10.83M
Shares Out 64.36M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 81,179
Average Volume 271,923
Open 0.4245
Previous Close 0.4200
Day's Range 0.4120 - 0.4250
52-Week Range 0.3020 - 1.0500
Beta -0.10
RSI 46.60
Earnings Date Aug 15, 2025

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.